Literature DB >> 17464765

Separation methods of T cells, natural killer, and dendritic cells from peripheral blood of cancer patients using interleukin-2 and functional analysis of natural killer cells after separation.

Norimasa Matsushita1, Atsushi Aruga, Yasunobu Kobayashi, Keishi Tanigawa, Masakazu Yamamoto.   

Abstract

We aimed to induce three different immune cell subsets from a single blood sample from cancer patients to target different biological characters of cancer cells. In the presence of 6000 IU/ml IL-2, natural killer (NK) cells adhere to plastic. By using this ability, we could separate dendritic cells, T cells, and NK cells from peripheral blood mononuclear cells. The cultured NK cells demonstrated higher nonspecific cytotoxicity against tumor cell lines than did the T cells. Furthermore, adherent NK cells demonstrated higher cytotoxicity than nonadherent NK cells, although there was no difference between adherent and nonadherent NK cells in natural cytotoxicity receptors (NKp30, NKp44, NKp46) and NKG2D expression. With these results, we confirmed that we could induce dendritic cell, T cell, and higher cytotoxic NK cells from a single blood draw, and this methodology facilitates to the use of these cells for clinical grade conditions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17464765     DOI: 10.1080/08923970701277791

Source DB:  PubMed          Journal:  Immunopharmacol Immunotoxicol        ISSN: 0892-3973            Impact factor:   2.730


  2 in total

1.  Blocking KCa3.1 channels increases tumor cell killing by a subpopulation of human natural killer lymphocytes.

Authors:  Shyny Koshy; Danli Wu; Xueyou Hu; Rajeev B Tajhya; Redwan Huq; Fatima S Khan; Michael W Pennington; Heike Wulff; Patricia Yotnda; Christine Beeton
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240

2.  The Adjuvant Activity of Epimedium Polysaccharide-Propolis Flavone Liposome on Enhancing Immune Responses to Inactivated Porcine Circovirus Vaccine in Mice.

Authors:  Yunpeng Fan; Liwei Guo; Weifeng Hou; Chao Guo; Weimin Zhang; Xia Ma; Lin Ma; Xiaoping Song
Journal:  Evid Based Complement Alternat Med       Date:  2015-11-03       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.